Johnson & Johnson at JPMorgan Healthcare Conference Transcript
Good afternoon, everybody. I'm Chris Schott from JPMorgan and I'm joined by my colleague, Robbie Marcus, and we're very pleased to be hosting a fireside chat with J&J this afternoon. From J&J, we have Jennifer Taubert, Chairman of the Pharmaceutical division; as well as Ashley McEvoy, Chairman of Medical Devices.
Before we start, I did have to read an FD disclosure quickly here, and then we'll jump into questions. Please be aware, some of the statements we're making today may be considered forward-looking or utilize non-GAAP measures. Please refer to J&J's SEC filings, particularly the 10-K, which discusses the risks and uncertainties around such forward-looking statements as well as the website, investor.jnj.com, for reconciliations of comparable GAAP measures. Finally, any performance metrics today may represent results through and including the third quarter of 2019.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
